Foresite Capital Management IV’s Insmed INSM Stock Holding History

Foresite Capital Management IV’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-678,322	Closed	-$10.9M	–	14
2020 Q1	$10.9M	Sell	678,322 -751,196	-53%	-$17.8M	13.4%	4
2019 Q4	$34.1M	Hold	1,429,518	–	–	14.73%	3
2019 Q3	$25.2M	Sell	1,429,518 -131,667	-8%	-$2.54M	8.15%	3
2019 Q2	$40M	Buy	1,561,185 +27,302	+2%	+$761K	11.3%	2
2019 Q1	$44.6M	Sell	1,533,883 -443,353	-22%	-$11.5M	16.02%	1
2018 Q4	$25.9M	Buy	1,977,236 +176,649	+10%	+$2.82M	11.91%	2
2018 Q3	$36.4M	Hold	1,800,587	–	–	11.94%	1
2018 Q2	$42.6M	Buy	1,800,587 +1,362	+0.1%	+$35.1K	14.52%	1
2018 Q1	$40.5M	Buy	1,799,225 +919,315	+104%	+$24.2M	16.8%	1
2017 Q4	$27.4M	Buy	+879,910	New	+$26M	19.23%	1

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Foresite Capital Management IV's INSM Position: Q2 2020 in Review

Foresite Capital Management IV sold out of Insmed (INSM) in Q2 2020, closing a stake of 678,322 shares — an estimated $10.9M sold.

Foresite Capital Management IV first reported a position in INSM in Q4 2017 and held it in 10 quarters. The position peaked at $44.6M in Q1 2019. 191 funds tracked by Wall St. Rank hold INSM as of Q2 2020.

Foresite Capital Management IV reported no remaining Insmed position as of Q2 2020 after selling out during the quarter.
Foresite Capital Management IV sold 678,322 Insmed shares in Q2 2020, an estimated $10.9M.
Foresite Capital Management IV first reported a position in Insmed in Q4 2017 and held it in 10 quarters.
Foresite Capital Management IV's Insmed position peaked at $44.6M in Q1 2019.
191 funds tracked by Wall St. Rank held Insmed as of Q2 2020.

Based on Foresite Capital Management IV's 13F filing for Q2 2020, filed 13 Aug 2020.